Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra

被引:0
|
作者
Tom N Grammatopoulos
Susan M Jones
Ferogh A Ahmadi
Brian R Hoover
Lawrence D Snell
Jesse Skoch
Vimal V Jhaveri
Andy M Poczobutt
James A Weyhenmeyer
W Michael Zawada
机构
[1] Denver and Health Sciences Center,Division of Clinical Pharmacology and Toxicology, Department of Medicine
[2] Denver and Health Sciences Center,Neuroscience Program, Department of Medicine
[3] University of Colorado at Denver and Health Sciences Center,Department of Pharmacology
[4] University of Illinois,Department of Cell and Structural Biology
关键词
Tyrosine Hydroxylase; Losartan; Ventral Tegmental Area; Angiotensin Converting Enzyme Inhibitor; MPTP Injection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra
    Dietz, Gunnar P. H.
    Stockhausen, Kerstin V.
    Dietz, Birgit
    Falkenburger, Bjoern H.
    Valbuena, Paola
    Opazo, Felipe
    Lingor, Paul
    Meuer, Katrin
    Weishaupt, Jochen H.
    Schulz, Joerg B.
    Baehr, Mathias
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 (03) : 757 - 765
  • [22] ALTERATIONS IN THE ROUGH ENDOPLASMIC-RETICULUM IN MPTP-INDUCED SUBSTANTIA-NIGRA DEGENERATION IN THE SQUIRREL-MONKEY
    FORNO, LS
    DELANNEY, LE
    LANGSTON, JW
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 297 - 297
  • [23] Neurogenic and dopaminergic neurogenic responses in the substantia nigra (SN) of MPTP-induced Parkinson's disease-like mice
    Luo, Chun
    Shan, Xiaoyang
    Chi, Liying
    Liu, Rugao
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 430 - 431
  • [24] Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats
    Lu, X
    Bing, G
    Hagg, T
    NEUROSCIENCE, 2000, 97 (02) : 285 - 291
  • [25] PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model
    Youn, Jong Kyu
    Kim, Dae Won
    Kim, Seung Tae
    Park, Sung Yeon
    Yeo, Eun Ji
    Choi, Yeon Joo
    Lee, Hae-Ran
    Kim, Duk-Soo
    Cho, Sung-Woo
    Han, Kyu Hyung
    Park, Jinseu
    Eum, Won Sik
    Hwang, Hyun Sook
    Choi, Soo Young
    BMB REPORTS, 2014, 47 (10) : 569 - 574
  • [26] Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of MPTP-induced Parkinson's disease-like mice
    Shan, XY
    Chi, LY
    Bishop, M
    Luo, C
    Zhang, Z
    Lien, L
    Liu, RG
    FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 : S64 - S64
  • [27] Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice
    Cook, R
    Lu, L
    Gu, J
    Williams, RW
    Smeyne, RJ
    MOLECULAR BRAIN RESEARCH, 2003, 110 (02): : 279 - 288
  • [28] ULTRASTRUCTURE OF NERVE-CELL DEGENERATION IN THE SUBSTANTIA-NIGRA IN EXPERIMENTAL MPTP-INDUCED PARKINSONISM IN THE MOUSE AND IN THE SQUIRREL-MONKEY
    FORNO, LS
    RICAURTE, GA
    DELANNEY, LE
    IRWIN, I
    LANGSTON, JW
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1986, 45 (03): : 376 - 376
  • [29] Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration
    Kim, Beom Keun
    Shin, Eun-Joo
    Kim, Hyoung-Chun
    Chung, Yoon Hee
    Dang, Duy-Khanh
    Jung, Bae-Dong
    Park, Dae-Hun
    Wie, Myung Bok
    Kim, Won-Ki
    Shimizu, Takao
    Nabeshima, Toshitaka
    Jeong, Ji Hoon
    NEUROCHEMISTRY INTERNATIONAL, 2013, 63 (03) : 121 - 132
  • [30] MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons
    Xu, Yingjiao
    Tang, Jie
    Liu, Chunyi
    Zhao, Chao
    Cao, Shanshan
    Yu, Huixin
    Chen, Zhengping
    Xie, Minhao
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : 9 - 18